Led by an interest in GLP-1 weight loss drugs, more health care brands may advertise in the Super Bowl this year.

GLP-1 medications have become popular for weight loss, and for good reason—they can help regulate appetite and support weight ...

The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

New research uncovers hidden risks and surprising benefits of weight loss drugs like Ozempic, reshaping how we see these ...

The actor said he lost 40 pounds taking GLP-1 medication before a negative side effect necessitated a change to a different ...

Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...

Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

American host and television producer Oprah Winfrey recently shared her initial experience of taking the weight loss drug GLP ...